Novartis | NVS - Trade Debtors

Stock Price
150.16
Daily Change
0.32 0.21%
Monthly
0.24%
Yearly
37.03%
Q2 Forecast
145.13

Novartis reported $12.29B in Trade Debtors for its fiscal quarter ending in December of 2025.





Trade Debtors Change Date
AbbVie USD 12.59B 180M Dec/2025
Amgen USD 9.14B 432M Mar/2026
AstraZeneca USD 17.88B 1.17B Mar/2026
Bausch Health Companies USD 2.19B 160M Mar/2026
Biogen USD 1.79B 76.6M Mar/2026
Bristol-Myers Squibb USD 14.36B 164M Mar/2026
Canopy Growth CAD 140.42M 113.56M Dec/2025
Corcept Therapeutics USD 39.07M 20.71M Mar/2026
Drreddys Laboratories INR 1.41B 11.6M Dec/2025
Eli Lilly USD 21.18B 1.02B Mar/2026
Gilead Sciences USD 4.74B 172M Mar/2026
GlaxoSmithKline GBP 7.94B 178M Mar/2026
Glaxosmithkline GBP 10.45B 707.81M Dec/2025
J&J USD 21.33B 3.72B Dec/2025
Merck USD 11.78B 345M Dec/2025
Novartis USD 9.6B 2.69B Mar/2026
Novartis USD 12.29B 3.3B Dec/2025
Pacira USD 125.64M 1.57M Mar/2026
Perrigo USD 697.1M 84.3M Mar/2026
Pfizer USD 16.17B 332M Mar/2026
Phibro Animal Health USD 215.87M 2.02M Dec/2025
Prestige Brands USD 191.92M 1.46M Mar/2026
Roche Holding CHF 11.9B 460M Dec/2025
Sanofi EUR 482M 85M Mar/2026
Sanofi EUR 397M 186.13M Dec/2025
Supernus Pharmaceuticals USD 182.18M 5.62M Mar/2026
Zoetis USD 1.51B 84M Mar/2026